Who owns AEONWS - AEON BIOPHARMA INC - *W EXP 07/21/202 based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

AEON BIOPHARMA INC - *W EXP 07/21/202 (AEONWS) Institutional Ownership

Q: What is CUSIP 00791X118?

CUSIP 00791X118 is the security identifier used in SEC filing datasets for AEONWS - AEON BIOPHARMA INC - *W EXP 07/21/202.

CUSIP: 00791X118

13F Institutional Holders and Ownership History from Q2 2023 to Q2 2024

Type / Class: Equity / *W EXP 07/21/202
Symbol: AEONWS

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 00791X118?
CUSIP 00791X118 identifies AEONWS - AEON BIOPHARMA INC - *W EXP 07/21/202 in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 00791X118:

Q2 2024 (0 holders) Q1 2024 (28 holders) Q4 2023 (30 holders) Q3 2023 (35 holders) Q2 2023 (0 holders)

Institutional Holders of AEON BIOPHARMA INC - *W EXP 07/21/202 (AEONWS) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Calls Notional Value	Price (Median)	Investors
2024 Q2	0	$0	-$3,328,191	$0		0
2024 Q1	2,278,641	$3,327,456	-$609,355	$271,177	$1.45	28
2023 Q4	4,356,029	$421,526	-$6,404	$20,290	$0.10	30
2023 Q3	4,635,249	$703,838	+$703,838	$41,245	$0.15	35
2023 Q2				$5,665	$0.17	0